COMP <GO>
CLBT vs SPSC // RSI-14 & 200D SMA MOMENTUM
Cellebrite DI Ltd. (NASDAQ) VS. SPS Commerce Inc. (NASDAQ) • 15-METRIC TALLY: CLBT 6
— SPSC 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CLBT
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
rsi-technicals
58.1
LAST: $85.78 (+0.22%) • MKT CAP: $3.09B
rsi-technicals
44.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLBT VS. SPSC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLBT | SPSC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.20% | 69.20% | +15.00 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.60% | 11.40% | +3.20 | CLBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 38.1x | 20.9x | +17.20 | SPSC | /valuation <GO> |
| Free Cash Flow Yield | 5.19% | 4.93% | +0.26 | CLBT | /fcf-yield <GO> |
| Operating Margin | 14.00% | 15.70% | -1.70 | SPSC | /operating-margins <GO> |
| Net Profit Margin | 16.50% | 12.40% | +4.10 | CLBT | /net-margins <GO> |
| Revenue Growth (YoY) | 18.60% | 17.80% | +0.80 | CLBT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.95 | 11.13 | -6.18 | SPSC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 58.1 | 44.6 | +13.52 | CLBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.1x | 27.8x | +5.30 | SPSC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.09B | $3.09B | -$1.6M | SPSC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLBT REV | SPSC REV | CLBT GROSS % | SPSC GROSS % | CLBT FCF | SPSC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $475.7M | $751.5M | 84.2% | 69.2% | $160.3M | $152.3M |
| FY 2024 | $401.2M | $637.8M | 84.4% | 67.0% | $123.6M | $137.4M |
| FY 2023 | $325.1M | $536.9M | — | — | $102.1M | $132.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLBT // BETA —
SPSC // BETA —